Omeros | Fremdkapital





Fremdkapital Veränderung Datum
Adma Biologics USD 70.08M 3.32M 2025-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Cytokinetics USD 158.75M 554.3M 2025-09
Dynavax Technologies USD 220.97M 214K 2025-09
Gilead Sciences USD 22.14B 5M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Immunic USD 0 0 2024-06
Insmed USD 539.72M 21.23M 2025-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
MacroGenics USD 70.26M 4K 2025-09
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 376.72M 1.37M 2025-09
Pfizer USD 57.41B 93M 2025-09
Rockwell Medical USD 8.65M 89K 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Xoma USD 94.38M 7.82M 2025-09


Omeros Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.